NCT05462496 2024-10-15
Modulation of the Gut Microbiome With Pembrolizumab Following Chemotherapy in Resectable Pancreatic Cancer
Icahn School of Medicine at Mount Sinai
Phase 2 Recruiting
Clinical Trials
5 trialsNCT06115174 2023-11-02
CRC - PTX
Tanta University
Phase 4 Unknown
NCT02713373 2022-10-06
Cetuximab and Pembrolizumab in Treating Patients With Colorectal Cancer That is Metastatic or Cannot Be Removed by Surgery
Roswell Park Cancer Institute
Phase 1/2 Completed
NCT02254941 2022-03-16
Observational Study to Evaluate the Use of Targeted Therapies in Metastatic Colorectal Cancer
Grupo Espanol Multidisciplinario del Cancer Digestivo
Unknown
NCT00956436 2013-09-16
Sorafenib With BIIB022 in Hepatocellular Carcinoma (HCC)
Biogen
Phase 1 Completed